Alzheimer's: The Costliest Killer.

The article discusses the need to have adequate reasearch funds to make successful clinical trials in treating Alzheimer's disease, which is considered the financial sinkhole in the 21st century. According to Dr. Michael Shelanski of the Taud Institute at Columbia University Medical Center, the tight research budgets discourage the bright young people to make advances of the illness. The claims of politicians including U.S. President Barack Obama to support finance in research is cited.